# Enduraphin, Inc. — Form D

Enduraphin, Inc. of Binghamton, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-25. $100K was reported sold. Industry: Manufacturing.

## Offering

- Filed: 2018-05-25
- Form: D
- Accession: 0001741981-18-000001
- Industry: Manufacturing
- Exemptions: 06b
- Amount sold: $100K
- Minimum investment: $10K
- Investors: 6
- Date of first sale: 2018-05-24
- Revenue range: No Revenues
- SEC file number: 021-313311

## Issuer

- Name: Enduraphin, Inc.
- CIK: 0001741981
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 120 Hawley Street, Binghamton, NY, 13901
- Phone: 315-450-5009

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Michael S Dalberth | Director | Clay, NY |
| Daniel M Drake | Director | Cicero, NY |
| Michael S Dalberth | Executive Officer | Clay, NY |
| Daniel M Drake | Executive Officer | Cicero, NY |

## More

- [CIK 1741981 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1741981&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001741981-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.